European life sciences venture capital company Forbion has raised two oversubscribed funds totalling €1.35 bn.
Up To Date
Latest News
German radiopharmaceuticals developer Ariceum Therapeutics has raised a further €22.75m extension of its €25m...
Genmab and argenx have entered a multiyear collaboration bringing together capabilities to jointly discover,...
Swiss Adaptyv Biosystems Sàrl has launched two fast-feedback tools that allow cheap, rapid and minaturised...
Ultrasound that switches cancer drug on could significantly reduce chemotherapy side effects, German...
At the beginning of April, the FAO presented a report entitled "Food safety aspects of cell-based food" to...